Hearst Now

Cancer Treatment Breakthrough

Skin Cancer Drug Tested in Texas Secures FDA Approval


The U.S. Food and Drug Administration approved the first drug to combat the second most common type of skin cancer. The drug, tested in San Antonio, has been called 'an oncology breakthrough.'

San Antonio Express-News
Hearst News

Hearst Connecticut Media Group and The Connecticut Mirror Announce Partnership

NEW YORK, September 28, 2018 – Hearst Connecticut Media Group has entered into a content partnership with the Connecticut News Project, Inc.’s The Connecticut Mirror.

More News
2017 Year-End Letter

In 2017, Hearst achieved record profits for the seventh straight year. President & CEO Steven R. Swartz reviews Hearst's 2017 highlights.

Read More
Annual Review 2017

Hearst President & CEO Steven R. Swartz reviews Hearst's 2017 highlights. Take a closer look at the moments that make up a day in the #HearstLife.

Read More
HearstLive

Discover the day's top news, entertainment and information through the lens of Hearst's 360+ businesses and partners.

See What's Live